2 hasil untuk "Patrick Zueger"
Menampilkan 1–2 · 0,80 detik · RSS
-
Artikel Jurnal Teks lengkap
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
BACKGROUND: The Janus kinase inhibitor upadacitinib is a potential treatment for psoriatic arthritis. The efficacy and safety of upadacitinib as compared with adalimumab, a tumor necrosis factor α inhibitor, in patients who have an inadequate response to nonbiologic disease-modifying antirheumatic…
-
Artikel Jurnal Teks lengkap
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
BACKGROUND: Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA). We evaluated upadacitinib in patients with PsA and prior inadequate response or intolerance to at least one biologic disease-modifying antirheumatic drug (DMARD). METHODS: In this…